Bisoprolol improves perfusion of ischaemic myocardium in anaesthetized pigs.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 1854165)

Published in Br J Pharmacol on October 01, 1988

Authors

L M Sassen1, M O den Boer, R J Rensen, P R Saxena, P D Verdouw

Author Affiliations

1: Laboratory for Experimental Cardiology (Thoraxcenter), Erasmus University Rotterdam, The Netherlands.

Articles cited by this

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75

Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest (1975) 2.58

Effects of propranolol on regional myocardial function, electrograms, and blood flow in conscious dogs with myocardial ischemia. J Clin Invest (1977) 1.27

Distribution of coronary collateral flow in acute myocardial ischaemic injury: effect of propranolol. Cardiovasc Res (1976) 1.26

Anti-arrhythmic effects of prazosin and propranolol during coronary artery occlusion and re-perfusion in dogs and pigs. Br J Pharmacol (1984) 1.15

[Clinical trials with analgesia in the swine using the neuroleptic Azaperone and the hypnotic Metomidate. 1]. Dtsch Tierarztl Wochenschr (1970) 1.07

Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res (1987) 1.04

Effect of propranolol and isoprenaline on regional left ventricular blood flow in experimental myocardial ischaemia. Cardiovasc Res (1975) 1.03

Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs. J Cardiovasc Pharmacol (1985) 0.97

Effects of methysergide and 5-hydroxytryptamine on carotid blood flow distribution in pigs: further evidence for the presence of atypical 5-HT receptors. Br J Pharmacol (1984) 0.95

Improvement by propranolol of regional myocardial dysfunction and abnormal coronary flow pattern in conscious dogs with coronary narrowing. Am J Cardiol (1978) 0.90

Systemic and regional myocardial responses to AR-L 115 BS, a positive inotropic imidazo-pyridine, in the absence or in the presence of the bradycardiac action of alinidine. Basic Res Cardiol (1981) 0.89

Changes in cardiac mechanics and coronary blood flow of regionally ischemic porcine myocardium induced by diltiazem. Chest (1980) 0.87

Iloprost (ZK 36374) enhances recovery of regional myocardial function during reperfusion after coronary artery occlusion in the pig. Br J Pharmacol (1986) 0.86

Acute coronary artery occlusion-reperfusion arrhythmias in pigs: antiarrhythmic and antifibrillatory evaluation of verapamil, nifedipine, prenylamine and propranolol. Eur J Pharmacol (1984) 0.86

Comparative effects of cardioselective versus noncardioselective beta blockade on subendocardial blood flow and contractile function in ischemic myocardium. Am J Cardiol (1979) 0.85

Prevention of ventricular fibrillation by metoprolol in a pig model of acute myocardial ischaemia: absence of a major arrhythmogenic role for cyclic AMP. J Mol Cell Cardiol (1986) 0.84

Improvement of perfusion and function of ischaemic porcine myocardium after reduction of heart rate by alinidine. J Cardiovasc Pharmacol (1981) 0.84

Systemic haemodynamic and beta-adrenoceptor antagonistic effects of bisoprolol in conscious pigs: a comparison with propranolol. Arch Int Pharmacodyn Ther (1987) 0.82

Effects of reperfusion on the regional contraction of ischemic and nonischemic myocardium following partial coronary obstruction. Circulation (1978) 0.82

Changes in ischemic blood flow distribution and dynamic severity of a coronary stenosis induced by beta blockade in the canine heart. Circulation (1981) 0.81

Beneficial actions of bevantolol on subendocardial blood flow and contractile function in ischemic myocardium. J Cardiovasc Pharmacol (1980) 0.81

Beta-adrenoceptor antagonists and blood flow to the jeopardized myocardium. Eur Heart J (1983) 0.80

Systemic and regional hemodynamic, antiarrhythmic and antiischemic effects of bevantolol in anesthetized pigs. Am J Cardiol (1986) 0.80

Pharmacodynamic profile of the selective beta 1-adrenoceptor antagonist bisoprolol. Arzneimittelforschung (1986) 0.79

Antagonistic effects of bisoprolol on several beta-adrenoceptor-mediated actions in anaesthetized cats. Eur J Pharmacol (1986) 0.79

Changes in regional blood flows and myocardial performance after administration of bisoprolol to pigs. Eur Heart J (1987) 0.77

[Ventricular arrhythmias in the acute stage of experimental swine myocardial infarct; effect of the beta blocker pindolol and the calcium antagonist Ro 11-1781]. Schweiz Med Wochenschr (1978) 0.77

The role of beta-adrenoceptors in coronary blood flow distribution in normal and ischemic canine myocardium. Eur J Pharmacol (1979) 0.77

Myocardial substrate utilization and hemodynamics following repeated coronary flow reduction in pigs. Basic Res Cardiol (1980) 0.77

Effects of oxyfedrine on global haemodynamics and myocardial lactate balance in acute ischaemia of the porcine heart preparation. Arzneimittelforschung (1981) 0.77

Articles by these authors

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev (1994) 7.11

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology (1986) 5.83

Myocardial protection by brief ischemia in noncardiac tissue. Circulation (1996) 2.91

Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation (1995) 2.25

Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect. Eur J Pharmacol (1974) 2.04

Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension (1994) 1.87

Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs (2000) 1.54

Ergotamine in the acute treatment of migraine: a review and European consensus. Brain (2000) 1.52

The effects of mianserin hydrochloride on the vascular responses evoked by 5-hydroxytryptamine and related vasoactive substances. Eur J Pharmacol (1971) 1.49

Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels. Neurology (2000) 1.47

Ischaemic preconditioning by partial occlusion without intermittent reperfusion. Cardiovasc Res (1994) 1.44

Porcine carotid vascular effects of eletriptan (UK-116,044): a new 5-HT1B/1D receptor agonist with anti-migraine activity. Naunyn Schmiedebergs Arch Pharmacol (1998) 1.42

Bradykinin-induced contraction of human peripheral airways mediated by both bradykinin beta 2 and thromboxane prostanoid receptors. Am J Respir Crit Care Med (1994) 1.41

Coronary side-effect potential of current and prospective antimigraine drugs. Circulation (1998) 1.36

Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int (2001) 1.36

Mediation of 5-hydroxytryptamine-induced tachycardia in the pig by the putative 5-HT4 receptor. Br J Pharmacol (1990) 1.31

Computer programs for the radioactive microsphere technique. Determination of regional blood flows and other haemodynamic variables in different experimental circumstances. Comput Programs Biomed (1980) 1.29

5-Carboxamide tryptamine, a compound with high affinity for 5-hydroxytryptamine1 binding sites, dilates arterioles and constricts arteriovenous anastomoses. Br J Pharmacol (1985) 1.25

5-Hydroxytryptamine-induced tachycardia in the pig: possible involvement of a new type of 5-hydroxytryptamine receptor. Br J Pharmacol (1988) 1.25

On serotonin and migraine: a clinical and pharmacological review. Cephalalgia (1993) 1.23

The effect of ergotamine on tissue blood flow and the arteriovenous shunting of radioactive microspheres in the head. Br J Pharmacol (1978) 1.22

Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation (1998) 1.16

Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries. J Am Coll Cardiol (1998) 1.16

Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous anastomotic blood flow. J Physiol (1982) 1.15

Mechanism of selective cardiac vagolytic action of pancuronium bromide. Specific blockade of cardiac muscarinic receptors. Eur J Pharmacol (1970) 1.15

Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways. Am J Respir Crit Care Med (1994) 1.14

The effects of antimigraine drugs on the vascular responses by-5-hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: possible pharmacological implications to their antimigraine action. Headache (1972) 1.14

Characterization of putative 5-HT7 receptors mediating tachycardia in the cat. Br J Pharmacol (1997) 1.14

Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension (1997) 1.14

Proto-oncogene expression in porcine myocardium subjected to ischemia and reperfusion. Circ Res (1992) 1.13

Angiotensin II type 1 (AT1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo. Hypertension (1997) 1.13

Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine--studies in an experimental model for migraine. Headache (1974) 1.12

Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks. Neurology (1992) 1.10

Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.10

Transmission of ultrasonic contrast through the lungs. Ultrasound Med Biol (1981) 1.07

Has melatonin a future as a cardioprotective agent? Cardiovasc Drugs Ther (2001) 1.07

Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart (2000) 1.06

Cardiovascular profile of pimobendan, a benzimidazole-pyridazinone derivative with vasodilating and inotropic properties. Eur J Pharmacol (1986) 1.06

Antiarrhythmic and hemodynamic actions of flecainide acetate (R-818) in the ischemic porcine heart. J Cardiovasc Pharmacol (1980) 1.05

Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pig. Br J Pharmacol (1991) 1.05

Increasing arterial wall injury after long-term implantation of two types of stent in a porcine coronary model. Eur Heart J (1998) 1.04

Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo. Circulation (2000) 1.04

The current endothelin receptor classification: time for reconsideration? Trends Pharmacol Sci (1994) 1.03

Antimigraine drugs and cranial arteriovenous shunting in the cat. Neurology (1980) 1.01

Tissue blood flow and localization of arteriovenous anastomoses in pigs with microspheres of four different sizes. Pflugers Arch (1985) 1.00

A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors. Arch Int Pharmacodyn Ther (1985) 1.00

Role of adenosine in the regulation of coronary blood flow in swine at rest and during treadmill exercise. Am J Physiol (1998) 1.00

Excitatory 5-hydroxytryptamine receptors in the cat urinary bladder are of the M- and 5-HT2-type. J Auton Pharmacol (1985) 1.00

N-(3-acetylaminophenyl)piperazine hydrochloride (BEA 1654), a putative 5-HT1 agonist, causes constriction of arteriovenous anastomoses and dilatation of arterioles. Eur J Pharmacol (1985) 1.00

Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-beta1. Am J Respir Cell Mol Biol (1998) 1.00

Haemodynamic changes and acetylcholine-induced hypotensive responses after NG-nitro-L-arginine methyl ester in rats and cats. Br J Pharmacol (1991) 0.99

Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J Mol Cell Cardiol (1997) 0.98

Autonomic control of vasomotion in the porcine coronary circulation during treadmill exercise: evidence for feed-forward beta-adrenergic control. Circ Res (1998) 0.98

Serum levels of tumor necrosis factor determine the fatal or non-fatal course of endotoxic shock. Immunol Lett (1991) 0.97

Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan. Br J Pharmacol (1991) 0.97

Redistribution of carotid artery blood flow by 5-HT: effects of the 5-HT2 receptor antagonists ketanserin and Wal 1307. Eur J Pharmacol (1984) 0.97

Endothelin receptors in the human coronary artery, ventricle and atrium. A quantitative autoradiographic analysis. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.97

Arteriovenous shunting and migraine. Res Clin Stud Headache (1978) 0.97

Comparative effects of the antimigraine drugs sumatriptan and ergotamine on the distribution of cardiac output in anaesthetized pigs. Cephalalgia (1992) 0.96

Heterogeneity of endothelin/sarafotoxin receptors mediating contraction of the human isolated saphenous vein. Eur J Pharmacol (1993) 0.96

Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II. Circulation (2000) 0.95

Effects of methysergide and 5-hydroxytryptamine on carotid blood flow distribution in pigs: further evidence for the presence of atypical 5-HT receptors. Br J Pharmacol (1984) 0.95

Ergotamine-induced constriction of cranial arteriovenous anastomoses in dogs pretreated with phentolamine and pizotifen. Cephalalgia (1983) 0.95

5-Hydroxytryptamine-induced contractions of the human isolated saphenous vein: involvement of 5-HT2 and 5-HT1D-like receptors, and a comparison with grafted veins. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.94

Analysis of alpha 1L-adrenoceptor pharmacology in rat small mesenteric artery. Br J Pharmacol (1999) 0.94

Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy. Eur J Pharmacol (1999) 0.94

Identification of acetylcholine, histamine, and 5-hydroxytryptamine in Girardinia heterophylla (Decne.). Can J Physiol Pharmacol (1966) 0.94

Investigation of the role of 5-HT1B and 5-HT1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses. Br J Pharmacol (1999) 0.94

Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol Sci (1993) 0.93

Low-dose aspirin inhibits platelet-induced contraction of the human isolated coronary artery. A role for additional 5-hydroxytryptamine receptor antagonism against coronary vasospasm? Circulation (1994) 0.93

The selective bradycardic effects of zatebradine (UL-FS 49) do not adversely affect left ventricular function in conscious pigs with chronic coronary artery occlusion. Cardiovasc Drugs Ther (1992) 0.92

Subcellular localization of angiotensin II in kidney and adrenal. J Hypertens (2001) 0.92

The canine external carotid vasoconstrictor 5-HT1 receptor: blockade by 5-HT1B (SB224289), but not by 5-HT1D (BRL15572) receptor antagonists. Eur J Pharmacol (1998) 0.92

Role of K(ATP)(+) channels in regulation of systemic, pulmonary, and coronary vasomotor tone in exercising swine. Am J Physiol Heart Circ Physiol (2001) 0.92

Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade. Hypertension (2001) 0.92

The effects of alinidine, an N-allyl derivative of clonidine, on regional myocardial perfusion and performance in the pig with or without atrial pacing. Eur J Pharmacol (1980) 0.92

Cardiac remodeling and contractile function in acid alpha-glucosidase knockout mice. Physiol Genomics (2001) 0.91

Coordinated expression of heme oxygenase-1 and ubiquitin in the porcine heart subjected to ischemia and reperfusion. Mol Cell Biochem (1996) 0.91

Nitric oxide contributes to the regulation of vasomotor tone but does not modulate O(2)-consumption in exercising swine. Cardiovasc Res (2000) 0.91

Regional and systemic haemodynamic changes evoked by 5-hydroxytryptamine in awake and anaesthetized rabbits. Eur J Pharmacol (1978) 0.91

Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation (1996) 0.91

Nicorandil-induced changes in the distribution of cardiac output and coronary blood flow in pigs. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.91

Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase. Cardiovasc Res (1999) 0.91

Carotid haemodynamics in pigs during infusions of 8-OH-DPAT: reduction in arteriovenous shunting is mediated by 5-HT1-like receptors. Br J Pharmacol (1989) 0.91

Acute systemic and regional hemodynamic effects of felodipine, a new calcium antagonist, in conscious renal hypertensive rabbits. J Cardiovasc Pharmacol (1984) 0.91

Domestic pigs in the study of myocardial ischemia. Eur Heart J (1983) 0.90